Signaling by RasG12V depends on EGFR activity in vivo
Patricia Vega-Cuesta, Ana López‐Varea, Ana Ruiz‐Gómez, José Félix de Celis
This study shows RasG12V mutants amplify EGFR signaling, accelerating ERK activation but requiring EGFR for full pathway activation, suggesting combined inhibition of Ras and EGFR could improve therapy for RasG12V tumors.
bioRxiv · Nov 12, 2025 · PreprintGenetics